- Home
- Articles
-
10.5606/tgkdc.dergisi.2018.14246
Spontaneous hemothorax as an adverse effect of rivaroxaban treatment
Hyang Rae Lee, Yi Yeong Jeong, Jong Deog Lee, Seung Jun Lee
Division of Pulmonology and Allergy, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, South Korea
DOI : 10.5606/tgkdc.dergisi.2018.14246
Although new oral anticoagulants are known to have decreased
bleeding risk compared to vitamin K antagonists, they may cause major
bleeding in rare cases. In this article, we report a 78-year-old female
patient who developed spontaneous hemothorax after rivaroxaban
use. Left-sided pleuritic chest pain occurred in the patient due to the
rivaroxaban she received for pulmonary thromboembolism. Diagnostic
thoracentesis revealed a grossly bloody pleural effusion. Rivaroxaban
was discontinued and the drainage of the hemothorax was performed
by fine needle aspiration. To our knowledge, this is the first case report
of rivaroxaban-induced spontaneous hemothorax, drawing attention to
major hemorrhagic complications of new oral anticoagulants.
Keywords : Hemothorax; pulmonary thromboembolism; rivaroxaban; spontaneous
Viewed : 6848
Downloaded : 1033